e-learning resources

ERS International Congress, Milan 2017

Browse by day:
Saturday, 09.09.2017
Sunday, 10.09.2017
Monday, 11.09.2017
Tuesday, 12.09.2017
Wednesday, 13.09.2017

  

Sponsored symposia:

Industry Evening Symposium at ERS 2017: “Evolving Concepts in Asthma with Type 2 Inflammation: the Role of Biologics”

Citations should be made in the following way: Authors. Title. Eur Respir J 2017; 50: Suppl. 61, abstract number.

Wednesday, 13.09.2017

08:30 - 10:30518In the frontline of the fight against tuberculosisHot topics
08:30 - 10:30519Update on weaning from the ventilatorSymposium
08:30 - 10:30520Treatment and prevention of COPD exacerbationSession
08:30 - 10:30521A novel approach to lung cancerHot topics
08:30 - 10:30522Chemical and biological indoor and outdoor pollutionHot topics
08:30 - 10:30523Personalised care for emphysema in COPDSymposium
08:30 - 10:30524Paediatric respiratory infections and immunityOral Presentation
08:30 - 10:30525From idiopathic pulmonary fibrosis (IPF) to rare diseasesOral Presentation
08:30 - 10:30526Novel imaging findings characterising various lung diseases and their prognosesOral Presentation
08:30 - 10:30527Hospital-acquired infections: from prevention to treatmentOral Presentation
08:30 - 10:30528New perspectives from experimental models of pulmonary hypertensionOral Presentation
08:30 - 10:30529New trends in pulmonary rehabilitation and chronic careOral Presentation
08:30 - 10:30530Notable abstracts in asthmaOral Presentation
08:30 - 10:30531Asthma: mechanisms and treatmentPoster Discussion
08:30 - 10:30532Assessing functional outcomes in chronic respiratory diseasePoster Discussion
08:30 - 10:30533CPAP therapyPoster Discussion
08:30 - 10:30534The acute patient: the clinical point-of-viewPoster Discussion
08:30 - 10:30535Monitoring asthma controlPoster Discussion
08:30 - 10:30536Asthma: clinical and epidemiologic characterisationPoster Discussion
10:45 - 12:45539Controversies in community-acquired pneumonia: a pro and con debateSymposium
10:45 - 12:45540Malignant pleural effusion management in 2017: a review of recent RCTsSymposium
10:45 - 12:45541From small airways dysfunction to dyspnoea in COPD: from physiology to clinical applicationSymposium
10:45 - 12:45542Innovation in diagnosing and monitoring respiratory diseaseSymposium
10:45 - 12:45543Omics in paediatric asthma and beyondSymposium
10:45 - 12:45544Pulmonary emergencies year in reviewYear in review
10:45 - 12:45545Smoking and molecular findingsOral Presentation
10:45 - 12:45546Towards new anti-inflammatory and anti-fibrotic agentsOral Presentation
10:45 - 12:45547Phenotyping obstructive sleep apnoeaOral Presentation
10:45 - 12:45548New immune markers for asthma and COPDOral Presentation
10:45 - 12:45549Treatment of multi-drug-resistant tuberculosis (MDRTB): where are we now?Oral Presentation
10:45 - 12:45550Lung cancer: latest basic research on molecular alterations, tumour-immune system-microenvironment interplay and the metabolomeOral Presentation
10:45 - 12:45551Innovation in pulmonary rehabilitation and chronic careOral Presentation
10:45 - 12:45552Idiopathic pulmonary fibrosis: from the bench to the bedsidePoster Discussion
10:45 - 12:45553New insights into pulmonary rehabilitation in patients with chronic lung diseasesPoster Discussion
10:45 - 12:45554Therapeutic approaches in lung diseasePoster Discussion
10:45 - 12:45555From the bench: therapeutic approaches in COPD and emphysemaPoster Discussion
10:45 - 12:45556Gene signatures in bronchial diseasesPoster Discussion
10:45 - 12:45557What is new in COPD management and prognosis: findings from large studies?Poster Discussion